GARY MORTON ANNUNZIATA, D.O.
Osteopathic Medicine at Bob Hope Dr, Rancho Mirage, CA
License number
California 020A66500
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
35900 Bob Hope Dr STE 275, Rancho Mirage, CA 92270
Phone
(760) 321-2500
(760) 321-5720 (Fax)
(760) 321-5720 (Fax)
Personal information
See more information about GARY MORTON ANNUNZIATA at radaris.comName
Address
Phone
70921 Windsor Cir, Rancho Mirage, CA 92270
39000 Bob Hope Dr, Rancho Mirage, CA 92270
98 Palma Dr, Rancho Mirage, CA 92270
70921 Windsor Cir, Rancho Mirage, CA 92270
69497 Las Gardenias, Cathedral City, CA 92234
Professional information
Chairman Board Of Managers At Desert Cities Health Managment Group Llc
Position:
Chairman Board Of Managers at Desert Cities Health Managment Group LLC, President at Gary M. Annunziata D.O. PC, Medical Director at Mirage Endoscopy Center, President at Desert Gastroenterology Consultants
Location:
Rancho Mirage, California
Industry:
Health, Wellness and Fitness
Work:
Desert Cities Health Managment Group LLC
since 2011
-
Chairman Board Of Managers
Gary M. Annunziata D.O. PC
since Sep 2006
-
President
Mirage Endoscopy Center
since Jun 2002
-
Medical Director
Desert Gastroenterology Consultants
since Jun 1995
-
President
Advanced Gastro Technologies Inc.
2007 - 2012
-
President
Physicians Hospital Desert Cities L.L.C.
Sep 2007 - Sep 2010
-
Chairman Board Of Managers
Education:
Midwestern University 1985 - 1989
D.O., Medicine Benedictine University 1982 - 1985
BS, Biology College of DuPage 1979 - 1982
A.S., Biology
D.O., Medicine Benedictine University 1982 - 1985
BS, Biology College of DuPage 1979 - 1982
A.S., Biology
Interests:
Aviation
Dr. Gary Annunziata, Rancho Mirage CA - DO (Doctor of Osteopathic Medicine)
Specialties:
Gastroenterology
Address:
Desert Gastroenterology Consult
35900 Bob Hope Dr SUITE 275, Rancho Mirage 92270
(760) 321-2500 (Phone)
Mirage Endoscopy Center
39935 Vista Del Sol SUITE 101, Rancho Mirage 92270
(760) 837-9210 (Phone)
35900 Bob Hope Dr SUITE 275, Rancho Mirage 92270
(760) 321-2500 (Phone)
Mirage Endoscopy Center
39935 Vista Del Sol SUITE 101, Rancho Mirage 92270
(760) 837-9210 (Phone)
Certifications:
Gastroenterology, 2007, Internal Medicine, 2002
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Desert Gastroenterology Consult
35900 Bob Hope Dr SUITE 275, Rancho Mirage 92270
Mirage Endoscopy Center
39935 Vista Del Sol SUITE 101, Rancho Mirage 92270
Eisenhower Medical Center
39000 Bob Hope Dr, Rancho Mirage 92270
35900 Bob Hope Dr SUITE 275, Rancho Mirage 92270
Mirage Endoscopy Center
39935 Vista Del Sol SUITE 101, Rancho Mirage 92270
Eisenhower Medical Center
39000 Bob Hope Dr, Rancho Mirage 92270
Education:
Medical School
Chicago College of Osteopathic Medicine / Midwestern University
Graduated: 1989
Luterhan Gen Hosp
Chicago College of Osteopathic Medicine / Midwestern University
Graduated: 1989
Luterhan Gen Hosp
Gary Morton Annunziata, Rancho Mirage CA
Specialties:
Gastroenterologist
Address:
35900 Bob Hope Dr, Rancho Mirage, CA 92270
Education:
Midwestern University Chicago, College of Osteopathic Medicine - Doctor of Osteopathy
Board certifications:
American Board of Internal Medicine Sub-certificate in Gastroenterology (Internal Medicine)
Method For Treating Obesity Using An Implantable Weight Loss Device
US Patent:
2008020, Aug 28, 2008
Filed:
Feb 27, 2007
Appl. No.:
11/711363
Inventors:
Gary Annunziata - Rancho Mirage CA, US
International Classification:
A61M 29/00
US Classification:
606191
Abstract:
The present invention provides methods of treating overweight or obese patients with an inflatable weight control device that is implanted in the patient's digestive tract. A first method comprises the steps of providing the weight control device which includes an inflatable body having a first bulb, a second bulb, an intermediate portion, and an internal passageway extending from the first bulb through the intermediate portion and to the second bulb. The inflatable body includes a valve assembly that is grasped by the endoscope during insertion of the weight control device in the patient's pylorus. Next, the endoscope is used to position the weight control device within the pylorus such that the intermediate portion resides within the pyloric valve and the first bulb resides within the pyloric antrum. The weight control device is then inflated with the endoscope such that the first bulb engages an inner surface of the pyloric antrum to form an outlet obstruction within the pyloric antrum. This obstruction causes chyme to accumulate proximate the first bulb prior to entering the internal passageway where it is then transported through the body and discharged from the second bulb into the patient's duodenum. The accumulation of chyme in pyloric antrum and the stomach causes the patient to feel full and stop eating. Thus, the treatment method provides a gastric outlet obstruction that slows the passage of chyme into the duodenum and as a result, the patient feels full and stops eating after consuming relatively small portions.
Implantable Weight Control Device
US Patent:
2008020, Aug 28, 2008
Filed:
Feb 27, 2007
Appl. No.:
11/711364
Inventors:
Gary Annunziata - Rancho Mirage CA, US
International Classification:
A61B 17/00
US Classification:
604175
Abstract:
The present invention provides an endoscopically implantable weight control device that forms a gastric outlet obstruction in a patient's digestive tract. The weight control device includes an inflatable body residing within the patient's pylorus and between the stomach and duodenum. The body features a first bulbous portion and a second bulbous portion, the exterior dimensions of the first bulbous portion exceeding the exterior dimension of the second bulbous portion. The body also includes an intermediate portion with exterior dimensions that are less than the exterior dimensions of both the first and second bulbous portions, wherein the intermediate portion resides within the patient's pyloric valve when the device is implanted. An internal passageway extends through the body, wherein the passageway receives and allows for the passage of chyme from the stomach to the duodenum. A method of treating obese patients with the inflatable weight control device utilizing a sequence of different-sized devices is also provided.